文献速递骨质疏松与代谢性骨病

利用腹部CT机会性筛查识别糖尿病患者中的骨质疏松与骨量减少

Using opportunistic screening with abdominal CT to identify osteoporosis and osteopenia in patients with diabetes.
PubMed 文献 · Osteoporos Int · 2020-07-05

该回顾性研究纳入313例同时接受腹部CT与DXA检查的糖尿病患者,比较L1椎体CT衰减值与DXA T值。有重大骨质疏松性骨折史者T值(-2.3±1.4 vs -0.9±1.4,p<0.001)和L1衰减值(104 HU±46 vs 149 HU±47,p<0.001)均低于无骨折者。L1衰减值≤135 HU对T值≤-1.5的敏感性和特异性分别为65%和69%,作者提出以此作为强烈考虑DXA筛查的阈值。

要点

  • 糖尿病患者中,有重大骨质疏松性骨折史者L1衰减值更低(104 HU±46 vs 149 HU±47,p<0.001)。
  • L1衰减值≤160 HU对骨质疏松的敏感性为91%,≤110 HU对骨质疏松的特异性为80%。
  • L1衰减值≤135 HU检测T值≤-1.5的敏感性和特异性分别为65%和69%。

核心结论

  • 腹部CT机会性骨质疏松筛查有助于判断糖尿病患者是否需要DXA筛查。
  • 作者提出L1衰减值≤135 HU作为检测T值≤-1.5的合理阈值,该T值可能与糖尿病患者脆性增加相关。

研究设计与样本

  • 回顾性研究,纳入313例糖尿病患者,受试者均在6个月内同时接受腹部CT和DXA检查。
  • 比较L1椎体CT衰减值与DXA T值,以确定既往在一般人群中建立的阈值的敏感性和特异性。

主要发现

  • 313例受试者中18例(5.8%)有既往重大骨质疏松性骨折史。
  • 有骨折史者T值为-2.3±1.4,无骨折史者为-0.9±1.4(p<0.001)。
  • 有骨折史者L1衰减值为104 HU±46,无骨折史者为149 HU±47(p<0.001)。
  • L1衰减值≤160 HU对骨质疏松的敏感性为91%,≤110 HU对骨质疏松的特异性为80%。
  • L1衰减值≤135 HU检测T值≤-1.5的敏感性和特异性分别为65%和69%。

关键数值与推荐

  • L1衰减值≤160 HU对骨质疏松的敏感性为91%。
  • L1衰减值≤110 HU对骨质疏松的特异性为80%。
  • L1衰减值≤135 HU检测T值≤-1.5的敏感性为65%,特异性为69%。

临床怎么用

  • 作者提出L1衰减值≤135 HU作为检测T值≤-1.5的合理阈值,该T值可能与糖尿病患者脆性增加相关;原文未据此给出进一步推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Opportunistic osteoporosis screening involves measuring the attenuation of L1 vertebrae on abdominal computed tomography (CT), which correlates with DXA T-score. We found that this approach is useful for detecting low bone mass in patients with diabetes and propose L1 attenuation ≤ 135 Hounsfield units (HU) as a threshold for which DXA should be strongly considered. INTRODUCTION: Attenuation of the L1 vertebrae on computer tomography (CT) images done for other reasons ("Opportunistic Osteoporosis Screening") has been found to correlate well with DXA-derived T-score. However, the method and the thresholds have never been tested specifically in those with diabetes mellitus (DM), in whom the fracture risk is greater than explained by BMD. METHODS: In a retrospective study of subjects with DM who had both abdominal CT and DXA within 6 months of each other, we compared L1 attenuation and DXA T-score to define the sensitivity and specificity of thresholds previously established in the general population. RESULTS: There were 313 subjects among whom 18 (5.8%) had prior major osteoporotic fracture (MOF). Subjects with MOF had lower T-scores (- 2.3 ± 1.4 vs. - 0.9 ± 1.4, p < 0.001) and L1 attenuation (104 HU ± 46 vs. 149 HU ± 47, p < 0.001) than non-fracture subjects. L1 attenuation ≤ 160 HU was 91% sensitive for osteoporosis, while ≤ 110 HU was 80% specific. For a higher T-score of ≤ - 1.5, L1 attenuation ≤ 135 HU showed balanced sensitivity and specificity (65% and 69%, respectively). CONCLUSION: Opportunistic osteoporosis screening with abdominal CT is useful in determining the need for DXA screening in subjects with diabetes. We propose L1 attenuation ≤ 135 HU as a reasonable threshold for detecting the T-score of ≤ - 1.5, which is likely associated with increased fragility in DM.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Jain RK, Lee E, Mathai C, et al. Using opportunistic screening with abdominal CT to identify osteoporosis and osteopenia in patients with diabetes. Osteoporos Int. 2020. PMID: 32623489. doi:10.1007/s00198-020-05521-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。